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ABSTRACT 
Aims. To develop standards and recommendations for transitional care for young people (YP) with 
juvenile onset rheumatic and musculoskeletal diseases (jRMD). 
Methods. The consensus process involved the following: 1) Establishing an international expert panel 
to include patients and representatives from multidisciplinary teams in adult and paediatric 
rheumatology 2) A systematic review of published models of transitional care in jRMDs, potential 
standards and recommendations, strategies for implementation and tools to evaluate services and 
outcomes; 3) Setting the framework, developing the process map and generating a first draft of 
standards and recommendations; 4) Further iteration of recommendations; 5) Establishing consensus 
recommendations with Delphi methodology; and 6) Establishing standards and quality indicators. 
Results. The final consensus derived 12 specific recommendations for YP with jRMD focused on 
transitional care. These included: high quality, multidisciplinary care starting in early adolescence; the 
integral role of a transition coordinator; transition policies and protocols; efficient communications; 
transfer documentation; an open electronic-based platform to access resources; appropriate training 
for paediatric and adult health care teams; secure funding to continue treatments and services into 
adult rheumatology; and the need for increased evidence to inform best practice. 
Conclusions. These consensus-based recommendations inform strategies to reach optimal outcomes 
in transitional care for YP with jRMD based on available evidence and expert opinion. They need to be 
implemented in the context of individual countries, health care systems and regulatory frameworks. 
 
INTRODUCTION 
Transitional care, as defined by the Society for Adolescent Medicine, is "the purposeful, planned 
movement of adolescents and young adults with chronic physical and medical conditions from child-
centered to adult-oriented health care systems".[1] Transition does not only focus on the 
administrative event of transfer of care between paediatric and adult providers; transition 
encompasses the process by which young people (YP) acquire skills and access resources to ensure 
that their physical, psychosocial, educational and vocational needs are met during transition to 
adulthood.[2] Adolescence and young adulthood reflect an important and unique developmental 
period for all YP who need education, support, guidance and planning to prepare them to be 
appropriately responsible and accountable for their own health and well-being as adults.[3] The same 
principle applies to YP with chronic illnesses (including juvenile-onset rheumatic and musculoskeletal 
diseases [jRMDs]) who need to acquire additional skills to independently manage their chronic illness. 
The case of need for transition is well described and transitional care aims to provide support and 
guidance so that YP can acquire the necessary skills and knowledge required to be independent, 
empowered and responsible adults.[4-7] 
The course of jRMDs often continues into adulthood; according to population-based inception cohort 
studies approximately half of YP with jRMDs enter adulthood with active disease, or develop flares of 
disease as adults. Many YP require ongoing and often long term treatment with complex 
immunosuppressive regimes.[8-10] Disease related sequelae are still observed, although with modern 
approaches to management, many YP are transferring to adult care in clinical remission albeit on 
medication.[11-13] All YP with jRMDs are, in principle, at significant risk of disability, early morbidity 
and limitations in participation later in life.[14, 15]These YP need continuous and developmentally 
appropriate care during and beyond adolescence to ensure optimal functioning in adulthood. 
However, the literature informs us that currently up to half of the YP do not make a successful transfer 
to adult rheumatology and are therefore at particular risk of unfavourable outcomes.[16-18] 
The importance of transitional care in YP with jRMD has been increasingly acknowledged.[19, 20] 
There is evidence regarding ‘best practice’ for transitional care, with emphasis on a holistic ‘life course’ 
approach to care.[21-23] Several healthcare institutions, specialties, and disease specific subgroups 
have developed and implemented transition programmes.[24-34] However, there is lack of clarity 
regarding the impact of transition programme on outcomes, and indeed, variance in what the 
outcomes should be.[35-40] A first consensus-based proposal regarding outcome indicators for 
successful health care transition was recently made by an international group of interdisciplinary 
health care professionals, patients and their families.[41] With rheumatology, there are significant 
gaps in current delivery of transition services and these include the unmet training needs for health 
care professionals in adolescent health and transitional care (resulting in lack of understanding and 
appreciation of the needs of YP), lack of transition readiness of YP (and/or of their parents/carers), and 
lack of robust quality indicators or cost-effective strategies.[2, 36, 42-48] 
Despite the limitations of the existing programmes, the gaps in knowledge and the paucity of 
resources, there is nonetheless commitment within the rheumatology communities (both adult and 
paediatric), to improve existing transitional care services. There is a strong desire for rheumatology-
specific guidelines for transition [48] and for these to be implemented across paediatric, adolescent 
and adult rheumatology health care settings. 
Objectives, scope, users and overarching principles 
The objective of the present initiative was to develop recommendations and standards for transitional 
care for YP with jRMDs, spanning ages from early adolescence (defined as 10 to 13 years), mid 
adolescence (14-16 years), late adolescence (17 to 19 years) to young adulthood (20 to 24 years).[49, 
50] These recommendations and standards are to be used to guide service development, benchmark 
the quality of transition services and be used by patient organisations to enhance patient expectations 
of care. We acknowledge that their implementation into clinical practice will be challenging and likely 
to be facilitated by stratification into ‘essential’ and ‘ideal’ components–essential defined as the 
minimum standards below which care would be deemed unacceptable and ideal being the standard 
that is regarded as excellent “optimal” care. 
The purpose of these recommendations and standards is to increase the profile of transition, optimise 
delivery of transitional care and improve patient experience within rheumatology across European 
countries. Specifically, the objectives are:  
 to ensure youth friendly and developmentally appropriate care 
 to improve physical, psychological, social, vocational and illness-related outcomes of YP with 
jRMDs 
 to facilitate continuity of care within adult rheumatology  
 to promote evidence based practice in transitional care 
 to facilitate clinical networks of health care professionals (paediatric and adult) who are 
engaged, interested and trained in the care of YP 
The scope of these recommendations and standards refers to all persons involved in the care of YP 
with jRMDs that continue into adulthood including, but not restricted to, those in Table 1.  
Although these recommendations and standards are related to the specific needs of YP with jRMDs, 
our expert panel endorse the American Academy of Pediatrics, the American Academy of Family 
Physicians, and the American College of Physicians-American Society of Internal Medicine consensus 
statement on health care transitions for YP with special health care needs,[51, 52] position papers of 
the Society for Adolescent Medicine,[1, 53-55] the Canadian Paediatric Society,[56] the Royal 
Australasian College of Physicians,[57] and the WHO definition of adolescent-friendly health 
services.[58, 59] In addition, we emphasise key components integral to these recommendations and 
standards, namely the importance of a YP focus, multidisciplinary approach with equity of access, 
quality of care and flexibility; the latter acknowledging both the heterogeneity of YP development and 
potential impact of chronic illness. 
METHODS 
The consensus process underwent the following stages: 1) Establishing an international expert panel to 
include patients and representatives from multidisciplinary teams in adult and paediatric 
rheumatology; 2) A systematic literature review; 3) Setting the framework, developing the process 
map and generating a first draft of standards and recommendations; 4) Further iteration of 
recommendations; 5) Developing consensus recommendations with Delphi methodology; and 6) 
Establishing standards and quality indicators, as suggested by the EULAR Standard Operating 
Procedures.[60] 
The project convenors (HF, KM, LC) liaised to appoint clinical fellows (DC, LL) to work on the project. 
They then convened an expert multidisciplinary panel from adult and paediatric rheumatology across 
Europe (doctors and allied health professionals with interest in transitional care) and patient 
representatives (YP with jRMDs invited from existing patient groups). The aim was for the panel to 
reflect the diversity of Europe (namely geography, health care systems and cultures).  
A systematic literature review of existing models of transitional care in jRMD was performed, with 
emphasis on potential recommendations, standards, strategies for implementation and tools to 
evaluate services and outcomes.[61] 
The first ‘face-to-face’ meeting of the expert panel discussed results of the systematic review and 
agreed the following: 
i) purpose of the project, timelines, roles and planned outputs  
ii) the ‘process map’ of transitional care using MindManager™ software 
iii) a draft proposal of recommendations and standards relating to different elements of the 
process map; the proposed list was circulated after the meeting by email to the expert 
group and further feedback requested.  
A second ‘face-to-face’ meeting further refined the recommendations and standards based on 
feedback from the group. Appropriate quality indicators were also suggested for each 
recommendation and standard.  
The recommendations and standards were then listed as statements. A wider audience of a total  of 
195 adult and paediatric rheumatology clinicians (doctors and allied health professionals) were then 
invited to take part in an e-survey and give opinion of their level of agreement with each statement.  
The e-survey was disseminated through email lists held by professional groups (such as PReS, EULAR 
and rheumatology societies in different countries). All responses were anonymised. Participants were 
asked for their level of agreement with each statement (using a 10 point Likert scale, with 0 = No 
agreement through to 10= Total agreement) and a ranking exercise to identify “minimal” and 
“optimal” standards for each recommendation. The target number of respondents for the e-survey 
was 100 and the level of agreement set at 80% for acceptance (lower levels were to be then discussed 
by the expert panel, with further iterations of the statements proposed and then a second e-survey, if 
needed, to be disseminated). Once agreement was reached, the methodologist (LC), together with the 
clinical fellows (DC, LL), graded the level of evidence for each recommendation based on the Oxford 
Levels of Evidence, 2011 (available at http://www.cebm.net/index.aspx?o=5653) and assigned 
relevant quality indicators where appropriate. 
RESULTS – The recommendations and standards  
The recommendations and standards, reported as “minimal/essential” and “ideal/optimal” levels of 
care and quality indicators are listed below; they are also presented in table format with the level of 
evidence and agreement reached (Table 2). 
1. YP with jRMDs should have access to high quality, coordinated transitional care, delivered 
through partnership with health care professionals, YP and their families, to address their needs 
on an individual basis.  
High quality care means holistic care (which covers medical, psychosocial, educational and vocational 
aspects; see table 3) with a multidisciplinary approach and is based upon regular assessments of the 
disease status in the context of developmental stage, life events and personal aspirations of YP. This 
care needs to be ‘future-focussed’, albeit not limited to young adulthood, in order to ensure optimal 
well-being.[19, 23]   
Ideal- Provision of a broad set of health care services led by providers who have specialist knowledge 
about jRMDs and adolescent health; Essential: care providers who refer to other agencies and services 
who can appropriately assist with transition issues. 
2. The transition process should start as early as possible; in early adolescence or directly after the 
diagnosis in adolescent-onset disease. 
Specifically for childhood onset diseases, the transition process should start by early adolescence (11 
years) (Ideal) or 14 years at the latest (Essential) in order to allow the development of the necessary 
self-care skills and optimise educational and vocational outcomes.[62, 63] For YP who are diagnosed 
over the age of 14 years the transition process should start at the time of diagnosis with the skills and 
support for transition built up over time. The transition process or joint care programs should enclose 
early adulthood, because young adults continue to have difficulties making effective linkages with 
adult care. Brain development continues and risk behaviours remain and may increase in the third 
decade, which have to be considered by proactive and preventive care.[64] 
3. There must be ‘direct’ communication between the key participants (and as a minimum, to 
include the YP, parent/carer, and a member of each of the paediatric and adult rheumatologist 
teams) during the process of transition. Before and after the actual transfer there should be 
‘direct’ contacts between paediatric and adult rheumatologist teams. 
A network of adult rheumatologists interested, engaged with and trained in adolescent rheumatology, 
must be identified and known to the paediatric rheumatology team. The network should work within 
agreed pathways to facilitate transition and expedite early, active planning of transition. Ideally, there 
should be a combined meeting between the young person and his or her family, the paediatric and 
adult health care provider.[65-67] As a minimum, there should be at least two ‘direct’ contacts by 
telephone or email between the paediatric and adult rheumatology team (and documented in a 
written communication); one before and one after the transfer. Copies of written communications are 
to be made available to YP and families.  Online supplementary table contains suggested guidelines 
regarding the content and format of communications at different stages of transitional care. 
4. Individual transition processes and progress should be carefully documented in the medical 
records and planned with YP and their families.  
Documentation should support the YP engagement and self-management skills, resilience and 
readiness for transfer.[68-72] This documentation should be tailored to local services, shared with the 
YP, and contribute to the medical summary. The inclusion of sensitive or confidential information (e.g. 
abortion, mental health problems) should be discussed with the YP. Ideally, there is a specific written 
individual transition plan,[26] which can be derived from a transition plan or passport example, such as 
http://www.uhs.nhs.uk/Media/Controlleddocuments/Patientinformation/Childhealth/Ready-Steady-
Go-Transition-plan.pdf.[21] As a minimum, the existence of a transitional care process has to be 
documented in the medical records. Additional resources are listed in Supplementary material. 
5. Every rheumatology service and clinical network—paediatric and adult—must have a written, 
agreed, and regularly updated transition policy. 
Policies and protocols should be agreed with all major stakeholders, including YP, families and all 
health care professionals and as equal partners;[27, 33, 61] it is important to stress the need to include 
all specialists (and not just in rheumatology) and primary care physician(s) who are involved in the 
clinical care of YP with jRMD [28] Hospital or institutional managers will have to agree to these policies 
to facilitate appropriate resources to support their implementation within the clinical departments. As 
a minimum, there must be a transition policy and the documents should be updated at least every five 
years. It is acknowledged that there is need for flexibility of the arrangements in transition policy and 
care pathways at a network level. 
6. There should be clear written description of the multidisciplinary team (MDT) involved in 
transitional care, locally and in the clinical network. The MDT should include a designated 
transition coordinator.  
The team for transitional care should reflect the multidisciplinary approach, i.e. doctors and other 
health professionals, such as nurses, physical therapists, psychologists, occupational therapists (OT), 
and youth or social workers.[28, 73, 74] It is recognised that certain roles within transition are likely to 
be addressed by different members of the MDT.[75] In addition, it is acknowledged that the 
composition of MDTs is variable and that some members may have more than one role. Ideally, there 
is personal continuity in the health professionals within the MDT providing care.[43] This provision of 
roles and services may be shared with other specialist services and not devoted solely to jRMDs. There 
should be a nominated and identified member of the MDT who is responsible as transition coordinator 
(Essential). This person can be a nurse or other health professional and should liaise between adult 
and paediatric teams to ensure the coordination of care, facilitation of communication and 
implementation of the transitional care plan including transfer.[61]  
7. Transition services must be YP focused, be developmentally appropriate and address the 
complexity of YP development.  
Components of YP focused care need to include: accessibility to specialised health care, staff attitudes, 
communication, medical competency, guideline-driven care, age appropriate environments, and youth 
involvement in health care.[76] Ideally, there should be a care facility that is truly adolescent-friendly 
staffed by professionals with expertise in adolescent care. The care should be organised to minimise 
the frequency of appointments and interruption to the daily life of YP. The aim of the consultations 
with the MDT is to enable YP to take lead role instead of the parent / carer(s), whilst also supporting 
the parent/carer(s) in their changing roles.[43, 77, 78] 
YP with jRMDs should have access to peer discussion and support through advisory group(s) and 
charity networks. Signposting to such groups and networks is the responsibility of the clinic where the 
YP attends. As a minimum, transitional care services should be led by staff with expertise and training 
in adolescent and young adult healthcare.  
8. There must be a transfer document. 
The format and content of transfer documents should be agreed by paediatric and adult teams and 
with patient input where possible. The transfer document should include, as a minimum, a medical 
summary with the diagnosis, any comorbidities, vaccinations, any complications of disease or 
treatments, the professionals involved in care, current and previous treatments (with reasons for 
changing treatments and any adverse events). Ideally, it should also include: i) Psychosocial aspects 
and educational / vocational status at the time of transfer, and ii) A report on self-management skills, 
to include readiness for transfer and procedural pain management strategies (e.g. for joint injections 
with or without general anaesthesia).[79] 
This transfer document may also include contributions from members of the MDT as appropriate and 
if relevant. Any confidential information or sensitive information to be included in the transfer 
document should be discussed with the YP; if needed, this should be included in a separate letter to 
the adult rheumatologist and be written ahead of the first consultation with adult rheumatology. 
Copies of the transfer document should be available to YP themselves in an easy read format if 
appropriate, and to all health care providers, including primary care, involved in the young person’s 
care.[80] 
9. Health care teams involved in transition and adolescent-young adult care must have appropriate 
training in generic adolescent health and childhood onset RMD.  
All members of the clinical MDT (from adult and paediatric rheumatology) engaged in transition are to 
have training on adolescent health and the process of transition.[46, 48] As a minimum, the key 
training components to be covered are: 1) jRMDs (presentation in childhood, knowledge and 
approaches to management), 2) Adolescence health and the impact on jRMDs, 3) Skills and knowledge 
to address emotional, mental health and social issues, 4) Promotion of healthy lifestyle and generic 
health issues, 5) Promotion of self-management and shared decision making, 6) Communication skills 
with young people and their parent/carer(s). 
These skills and knowledge can be acquired through different ways of learning (e.g. to include clinical 
experience, e-learning, and practical workshops) and should be a component of continuous 
professional development. There are many courses and e-learning opportunities available, such as the 
EULAR/PReS On-line Course in Paediatric Rheumatology 
(www.eular.org/edu_online_course_paediatric.cfm), the EuTEACH-European Training in effective 
adolescent health and care (www.unil.ch/euteach/en/home.html) or the UK Adolescent Health Project 
(www.e-lfh.org.uk). Reciprocal periods of training for members of the adult and paediatric 
rheumatology teams are advocated (Ideal). 
10. There must be secure funding for dedicated resources to provide uninterrupted clinical care and 
transition services for YP entering adult care. 
The following are regarded as essential for transitional care programmes; 
i) The funding and supporting resources for care should be dependent on clinical need and 
should not be interrupted on sole grounds on the age of the patient. Conversely, the presence 
or absence of resources should not define the timing of transfer.  
ii) Funding of (biological and other) therapies should continue if clinically indicated irrespective of 
patient age and transfer to adult care.  
iii) Funding of the paediatric and adult MDTs involved in the transitional care is needed.  
iv) The transition coordinator role and administration support for clinical networks must be 
funded. 
v) The training for the MDT along with continuous professional development support must be 
funded 
vi) The importance of adequate administrative support is likely to be a determinant of successful 
transfer.[45, 48, 80] 
11. There must be a freely accessible electronic-based platform to host the recommendations, 
standards, and resources for transitional care. 
An open resource e-platform (Essential), such as the EULAR / PReS website, to host resources to 
support the transition process, staff training and patient resources, would facilitate setting up of new 
and further development of existing transition services. All stakeholders must have access to these 
resources, including YP with jRMDs, their families and healthcare professionals in hospital, primary and 
community care involved. The resources must be endorsed (Essential) by professional bodies such as 
EULAR / PReS, consumer groups and charities in the respective countries.  
12. Increased evidence-based knowledge and practice is needed to improve outcomes for YP with 
childhood onset RMD. 
The expert group recognised the need for a greater evidence base to inform best practice, the best 
metrics for measuring “success” and “outcome” of transitional care programmes and the impact of 
such programmes on YP with jRMDs.[7, 37, 38] The agenda for research needs to include,  
i) The transition programme evaluation as a complex intervention[74]  
ii) The effectiveness of the transition process[61] and how this can be measured  
iii) The timeliness of interventions and validation of readiness tools,[68-72, 81] 
iv) The outcome measures of transition [37-39, 41, 82] and  
v) Predictors for transition outcomes 
vi) Cohort studies and registries from paediatric rheumatology to extend into adult life  
vii) An agreed ‘core transition dataset’ for routine practice in paediatric and adult rheumatology 
centres to inform and foster future research initiatives, facilitate a standardised approach 
in transitional care and enable comparative assessment of care across Europe. 
Standards and quality indicators 
The expert group concluded that there is a limited evidence base for outcomes of transition and for YP 
rheumatology services.[61] The expert group proposed, before the publication of the previous studies, 
key quality indicators to measure service delivery and to inform the research agenda. Supplementary 
table shows a list of standards and the agreed quality indicators. 
In 2015, Suris et al. coordinated an international consensus on key elements and one indicator of a 
good transition.[79] In most instances, such consensus underscored items related to coordination and 
communication as basis for good partnership between paediatric and adult providers. Another 
initiative, developed during our project, obtained a clinical practice-benchmark tool for transition to 
adult care in the United Kingdom through a process of mapping.[83] There is no single outcome of 
‘successful’ transition and potential indicators need to include clinical parameters (disease activity and 
status), patient (and family) experience (of care), psychosocial, educational and vocational status, 
quality of life measures, participation in adult life, engagement and attendance in adult health care, 
adherence to treatment, achievement of young adult developmental tasks. A recent taskforce 
identified, by Delphi methodology, outcomes of importance.[41] These included individual outcomes 
(quality of life, understanding the characteristics of conditions and complications, knowledge of 
medication, self-management, adherence to medication, and understanding health insurance), health 
services outcomes (attending medical appointments, having a medical home, and avoidance of 
unnecessary hospitalization), and a social outcome (having a social network). Measures need to be 
valid, reproducible and relevant.  
DISCUSSION 
This PReS / EULAR taskforce has developed the first international set of recommendations and 
standards for transitional care of YP with jRMDs; the aim being to facilitate high quality models of care 
for new and existing services, inform strategies for evaluation and define a research agenda. These 
were produced before the emergence of the 2016 NICE guidance on Transition in the UK 
(www.nice.org.uk/guidance/ng43) but reassuringly, are consistent NICE recommendations. Our 
methodology permitted critical appraisal of published models of care and incorporated opinion from a 
diverse expert specialists group including YP.[61] Our recommendations and standards set out the 
‘essential/minimal’ and ‘ideal/optimal’ components of transitional care and we anticipate that such 
stratification will be helpful to benchmark services and facilitate implementation and evaluation.   
The recommendations focus on transitional rheumatology care, however, they comprise components 
of high-quality transitional care derived from policy documents, guidelines relating to transitional care 
and the adolescent health literature. This underlines that, overall, most key elements of transitional 
care are generic. That is also reflected in the key elements for successful transition, which were 
published by Suris after the recommendations given here were agreed on.[79] Six elements were 
regarded as being essential by more than 70% of an international panel, of which two relate to 
establishing a good partnership between paediatric and adult professionals and the shared 
responsibility of transitional care. All six essential elements are included in the recommendations given 
here, which highlight the need for teams to work effectively together and engagement of different 
care providers within clinical networks. Addressing the challenges of ‘joined up’ working across 
paediatric and adult rheumatology and within clinical networks has also been highlighted by 
others.[84] Our recommendations, in agreement with other recent taskforces,[79, 83] emphasise the 
importance of identifying key individuals, the integral role of YP and families, written communication, 
agreed policy, training and clarity of roles within teams. Therewith, they focus on process areas that 
are most in need of improvement according to care providers and consumers, such as co-ordination, 
guidelines, protocols, and communication.[65] It is apparent that a transitional care pathway for YP 
with jRMDs can be implemented with a motivated health care team, the reorganisation of their 
existing work practice and available resources.[29, 31] The transitional care MDT also needs specific 
training in adolescent medicine and adequate capacity to enable the transition care coordinator role to 
function.[46, 48]. Transition is resource consuming. The expert panel stresses the fact that without 
sufficient funding or reimbursement of the specific interventions, transitional care services cannot 
become a normal part of health care for young people. Funding is needed for specific service provision 
and to ensure continuity of clinical care and access to medicines after transfer to adult care based on 
clinical need rather than age of the patient of the provider. There are promising examples in the U.K. 
or Germany, where the provision of transitional care services as part of clinical practice has been 
funded by the government or statutory health insurance companies within defined programmes.[32]  
The funding for continuity of clinical care and access to medicines after transfer to adult care has to be 
addressed and based on clinical need rather than age of the patient of the provider. Given the 
importance of transition for the many YP who transfer to adult rheumatology, we strongly suggest that 
transitional care is included in all PReS and EULAR activities to raise awareness, promote access to 
training and improve skills and knowledge amongst all adult rheumatology teams.  
Quality indicators and outcomes of transitional care are proposed. These transitional care outcomes 
are similar to most of 10 prioritized outcomes identified by a task force from the Health Care 
Transition Research Consortium [41] and may allow researchers to conduct focused evaluations of 
current processes and more detailed evaluations of interventions. 
We acknowledge differences between countries in how transition may be organized within different 
health care systems.[65, 85-87] Our recommendations are intended to be useful, widely applicable 
and promote transitional care. Although transitional care has received much attention in the child 
health community, little government attention has been paid to this complex health system issue. An 
analysis of policy profiles of paediatric-to-adult care transitions in six European countries revealed that 
four had currently no transition policies or strategies.[87] The overarching principles seek to promote 
transferability to different contexts, be compliant with national regulatory guidance and facilitate local 
teams to work together with responsibility and accountability for services to be suitable for local 
needs. Our approach is similar to that proposed by others; the Spanish consensus for transition 
management in patients with jRMDs[88] reported a framework with similar recommendations albeit 
with more practical details suited to the Spanish health care system. 
Transition is a time-variable process that prepares YP with jRMDs to take responsibilities for their lives 
and also their health issues. This process is critical in order to facilitate the actual transfer to adult 
care. Transition is therefore a complex process with many variables involved and the panel required 
considerable dialogue and indeed compromise to agree the aims, framework and process map to 
address such complexity. However, as the project evolved and moved forward, harmonisation became 
apparent and ultimately one round of Delphi was adequate to achieve high agreement. 
It is clear that there are many unanswered questions in transitional care. Our recommendations 
highlight the need for improved evidence base to inform models of care, identify relevant outcome 
measures and the cost effectiveness of transitional care programmes as a complex intervention. Much 
work is yet to be done, but it is important to identify and ultimately deliver ‘best’ care for YP with 
jRMDs and their families, to facilitate optimal physical, psychosocial and quality of life outcomes within 
adulthood.   
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Table 1. Individuals to whom these recommendations may prove useful. 
Adult and paediatric rheumatologists 
Other health care professionals:  
- nurses,  
- physiotherapists,  
- occupational therapists,  
- social workers,  
- psychologists,  
- youth workers,  
- primary care and other specialists (e.g., ophthalmology, dermatology, nephrology, 
orthopaedics) involved in share care and clinical networks 
General practitioners and health care professionals working in primary care  
Young people with RMD and other multisystem disease, their families and peers 
Professional groups or societies working with young people with RMDs 
Academics involved in Adolescent and Young Adult health research 
In addition, these standards and recommendations are intended to be useful to the remit of: 
- Educational and vocational services 
- Employers and careers advisory services 
- Charities and support organisations 
- Funders of clinical services 
- Health policy makers 
- Research funding bodies 
- Organisers of disease and/or drug registers, and cohort studies 
 
Table 2. Recommendations, standards, and proposed quality indicators on transitional care for 
young persons with RMD 
Recommendations LOE GR MA 
1. Young people (YP) with RMD should have access to high quality, coordinated 
transitional care, delivered through partnership with health care professionals, 
YP and their families, to address needs on an individual basis. 
5 D 9.6 
2. The transition process should start as early as possible; in early adolescence or 
directly after the diagnosis in adolescent-onset disease 
2b B 8.3 
3. There must be ‘direct’ communication between the key participants (and as a 
minimum, to include the YP, parent/carer, and a member each of the 
paediatric and adult rheumatologist teams) during the process of transition. 
Before and after the actual transfer there should be ‘direct’ contacts between 
paediatric and adult rheumatologist teams. 
5 D 9.3 
4. Individual transition processes and progress should be carefully documented in 
the medical records and planned with YP and their families.  
5 D 9.2 
5. Every rheumatology service and clinical network—paediatric and adult—must 
have a written, agreed, and regularly updated transition policy. 
5 D 8.9 
6. There should be clear written description of the multidisciplinary team (MDT) 
involved in transitional care, locally and in the clinical network. The MDT should 
include a designated transition coordinator. 
5 D 8.7 
7. Transition services must be YP focused, be developmentally appropriate and 
address the complexity of YP development. 
5 D 9.4 
8. There must be a transfer document.  
5 D 9.4 
9. Health care teams involved in transition and adolescent-young adult care must 
have appropriate training in generic adolescent care and childhood onset RMD. 
5 D 9.5 
10. There must be secure funding for dedicated resources to provide 
uninterrupted clinical care and transition services for YP entering adult care. 
5 D 9.4 
11. There must be a freely accessible electronic-based platform to host the 
recommendations, standards, and resources for transitional care. 
5 D 9.4 
12. Increased evidence-based knowledge and practice is needed to improve 
outcomes for YP with childhood onset RMD. 
5 D 8.5 
Abbreviations: LOE, level of evidence; GR, grade of recommendation; MA, mean agreement (0-10)  
 
 
 
 
 
 
 
Table 3. Aspects considered as part of holistic care. 
Medical aspects 
 identification of medical needs, addressing any issues 
 ensuring continuity of provision of high quality care 
 providing generic and disease-specific information 
 health promotion, anticipatory guidance 
 health behaviour (e.g. health literacy, experimentation and risk behaviour), 
negotiating most appropriate ways to ensure adherence to treatment  
 knowledge and skills in areas listed above 
Psychosocial aspects 
 identifying individual needs, risk and protective factors (e.g. HEADSS),[89, 90] 
 providing support or referring young people to specific agencies 
 ensuring a social life that is equivalent to those of peers  
 ensuring support to cope with disease/treatment 
 providing advice and/or additional sources of support 
 promoting skills in assertiveness, resilience, self-care, self-determination, and self-
advocacy 
Educational and vocational aspects: 
 addressing future career prospects 
 developing skills in disclosure 
 support in preparing for work readiness, 
 informing about where to get information (recommend: career advisors, 
appropriate agencies, charity websites) 
 addressing work experience and encouraging young people to gain relevant 
experience  
 offer appropriate information, support and advice (support groups, volunteer 
services) 
 liaisons with educational institutions 
 informing about rights and obligations, benefits and opportunities to adapt working 
(place, time) 
 
(Supplementary material) 1 
Selected resources that may aid designing and maintaining transitional services. 2 
Web site Description Useful to 
TRAINING RESOURCES    
http://www.unil.ch/euteach/home.html Provides objectives, strategies and resources for trainers and 
teachers.  
Healthcare 
professionals 
http://www.e-lfh.org.uk/programmes/adolescent-health/ The Adolescent Health Programme (AHP) is an e-learning 
programme for all healthcare professionals working with young 
people. 
Healthcare 
professionals 
http://www.talklab.nhs.uk  TalkLab's Better Conversations programme aims to improve the 
sometimes complex, three-way consultations doctors have with 
young people and their parents 
Health care 
professionals, young 
people and families 
http://www.usc.edu/adolhealth/ This site was developed for use by health care professionals 
involved in either the teaching of adolescent health or clinical care 
of adolescents and young adults. The material includes cases, 
questions, weblinks and references.  
Healthcare 
professionals 
GUIDANCE   
http://www.cps.ca/en/documents/authors-
auteurs/adolescent-health-committee#practice-points 
This website provides health professionals information needed to 
make informed decisions about the well being of children and 
youth. Parents, journalists and other stakeholders may also find 
this site useful. 
Healthcare 
professionals, young 
people and families. 
http://www.adolescenthealth.org/Clinical-Care This site provides resources to adolescent and young adult health Healthcare 
Web site Description Useful to 
Resources/Clinical-Care-Resource-Guides.aspx care providers and youth serving professionals. Include clinical care 
guidelines and resources. Most of the resources included are 
applicable in the U.S. and some are internationally applicable. 
professionals, young 
people  
https://www.nice.org.uk/guidance/ng43 This guideline of the National Institute for health and Care 
Excellence includes recommendations for transition. 
Healthcare 
professionals, young 
people and families. 
PROFESSIONAL ORGANISATIONS   
http://www.yphsig.org.uk/ Home page of the Young People's Health Special Interest Group of 
the Royal College of Paediatrics and Child Health, UK 
Healthcare 
professionals 
http://www.adolescenthealth.org Home page of the Society for Adolescent Health and Medicine Healthcare 
professionals 
http://www.iaah.org Home page of the International Association for Adolescent Health Healthcare 
professionals 
TRANSITIONAL CARE RESOURCES   
http://www.gottransition.org/ Include a complete compilation. Serve as a clearinghouse for 
current transition information, tools, and resources. Also in 
Spanish. 
Healthcare 
professionals, young 
people and families. 
http://depts.washington.edu/healthtr Include transition resources such as websites, checklists and tools 
for teens and young adults with disability or chronic illness. 
Healthcare 
professionals, young 
people and families. 
http://chfs.ky.gov/ccshcn/ccshcntransition.htm  Interesting website with Transition Resources, ages adapted Young people and 
Web site Description Useful to 
families 
http://www.chla.org/my-voice-adolescent-transition-
program 
Include information about Adolescent Transition Program Young People and 
families 
http://www.floridahats.org/ A health care transition tool box contains documents and links to a 
variety of local, state and national resources. Materials for youth, 
families and professionals are organized in several categories. 
Healthcare 
professionals, young 
people and families. 
http://www.sickkids.ca/good2go/ This site provides resources to youth, families, and health care 
professionals. 
Healthcare 
professionals, young 
people and families. 
http://www.ontracbc.ca/ Includes information about transition: preparation, transfer, and 
attachment to adult services. Includes toolkits for youth, 
parents/families, and care providers 
Patients, families and 
health care 
professionals 
http://www.transitioninfonetwork.org.uk Provides information about the transition process that is useful to 
disabled young people, parents/carers and professionals. 
Healthcare 
professionals, patients 
and families. 
http://www.chimat.org.uk/transitions  Resources and evidence relating to young people's transition 
process into the adult world. It is regularly updated 
Healthcare 
professionals, patients 
and families. 
http://www.uhs.nhs.uk/OurServices/Childhealth/Transitio
ntoadultcareReadySteadyGo/Transitiontoadultcare.aspx 
Description of the Ready Steady Go transition programme. Include 
resources for health professionals and useful links 
Young people, families 
and health care 
professionals 
Web site Description Useful to 
http://www.rch.org.au/transition/ Transition Support Service of Royal Children’s Hospital Melbourne, 
Australia. Includes fact sheets and tools, links, publications and 
others. 
Healthcare 
professionals, young 
people and families. 
RHEUMATOLOGY-SPECIFIC   
http://www.bspar.org.uk/adolescent-rheumatology Excellent website of British Society for Paediatric and Adolescent 
Rheumatology Include a complete compilation of useful resources 
for young people and professionals. 
Healthcare 
professionals, young 
people and families 
Paediatric Musculoskeletal Matters  
http://www.pmmonline.org 
Free website explaining the essentials of rheumatic diseases in 
children and young people and useful for support and training of 
shared care providers. 
Health care 
professionals  
http://www.healthtalk.org/young-peoples-
experiences/arthritis/transition-moving-adolescent-or-
adult-services 
This website provides free, reliable information about health 
issues, by sharing people's real-life experiences. 
 
Young people  
http://www.jatransition.org/ Website designed to prepare youth with rheumatic diseases and 
their families for the transition to healthy adulthood. 
Young people and 
families 
http://www.arthritisresearchuk.org/youngpeople Includes practice information for young patients, parents and also 
for patient school teachers. 
Young people and 
families 
http://www.jia.org.uk/transition Include useful resources about moving from paediatric to adult 
care. Includes a specific guide for parents 
Young people and 
families 
http://www.kidsgetarthritistoo.org/living-with-ja/daily-
life/transition/ 
Specifics resources for parents. Families 
Web site Description Useful to 
http://www.hopkinsarthritis.org/patient-
corner/transitioning-the-jra-patient-to-an-adult-
rheumatologist/ 
Explanation about Transitioning the JRA Patient to an Adult 
Rheumatologist: patient view 
Young people 
http://www.jong-en-reuma.nl/ Website created for and by young people with rheumatic diseases. 
In Dutch 
Young people 
http://www.reuma-uitgedaagd.nl/ Information for young people with rheumatic diseases. In Dutch Young people 
 1 
 2 
 3 
Standards at national level  1 
1. Adolescent and young adult care (including transition) is included in national training 2 
syllabuses (adult + paediatric) for all allied health professionals and doctors in adult and 3 
paediatric rheumatology. 4 
2. There is adequate IT infrastructure to facilitate communication between paediatric and adult 5 
rheumatology teams. 6 
Standards at unit level (minimum + ideal)  7 
1. There is a professional with a designated role for transition (i.e. ‘transition coordinator’) 8 
working between paediatric and adult rheumatology services 9 
2. There is a written transition policy agreed with paediatric and adult rheumatology networks 10 
and their supporting infrastructure (e.g. management teams, insurers, etc) 11 
3. There is a clinical transfer summary template agreed by paediatric and adult rheumatology 12 
4. There is adequate IT infrastructure to facilitate data collection, recording of outcome and 13 
quality indicators, and facilitating communication between paediatric and adult rheumatology 14 
teams 15 
5. There is evidence of young people being actively involved in service design and development 16 
6. There is a research programme on transition and adolescent and young adult care 17 
Standards at patient level (minimum + ideal) 18 
1. The YP attends the first two appointments in adult rheumatology  19 
2. The YP receives a clinical transfer summary produced by paediatric rheumatology and agreed 20 
by the young person, and this is received by adult rheumatology and primary care provider for 21 
every YP 22 
3. Outcome measures: 23 
a. achievement of transition readiness,  24 
b. disease knowledge,  25 
c. improved medication adherence  26 
d. disease control 27 
e. quality of life 28 
f. Participation 29 
g. young person or family satisfaction 30 
h. self advocacy 31 
i. self-management readiness  1 
j. resilience / independent living  2 
k. work stability and employment 3 
Quality indicators  4 
To test in the setting before and after the implementation of the health service. 5 
1. % Lost to follow-up after 1 year of transfer 6 
2. % no shows on visits in adult rheumatology after 1 year of transfer 7 
3. YP and family satisfaction with transfer process (e.g. Mind the Gap scale)[63, 89, 90] 8 
4. Satisfaction of members of the MDT 9 
5. The proportion of YP with a complete transfer document 10 
6. The number of contacts documented in the year before and after transfer for each YP 11 
7. An agreed written policy is in place 12 
8. The proportion of MDT staff completing the transition training programme 13 
9. An IT platform is available to host resources, tools, guidelines and policy documents  14 
10. Outcome measures: 15 
a. achievement of transition readiness 16 
b. disease knowledge 17 
c. improved medication adherence  18 
d. disease control 19 
e. quality of life 20 
f. Participation 21 
g. young person or family satisfaction 22 
h. self advocacy 23 
i. self-management readiness  24 
j. resilience 25 
k. independent living 26 
l. work stability and employment 27 
Suggested content and format of communication at different levels of transitional care. 1 
1) Communication between health professionals and patient: 
a) Developmentally-appropriate language, YP-oriented  
i) honest, realistic and jargon free 
ii) supportive dialogue 
iii) assisting young people to develop the communication skills that are necessary to manage 
and navigate services effectively 
iv) establishing a positive therapeutic relationship that enables young people to express 
opinions and make informed decisions about care  
b) Offering opportunities (enough time, independent of caregivers/parents, appropriate 
environment, talk to peers) for communication 
c) Developmentally-appropriate format (written, verbal, phone calls, emails, texting, referring to 
other forms of communication), 
d) Explain and assure confidentiality (e.g. before discussing sensitive topics)  
2) Communication between health professionals and family: 
It must be in a format that can be understood, and family-oriented: 
i) appropriate verbal and non-verbal communication 
ii) referring to other forms of communication 
iii) acknowledging parents knowledge base and pivotal role in caring 
iv) offering available supporting services  
v) respect rights to confidentiality of the young person 
3) Communication between health professionals: 
The members of the adult and paediatric rheumatology teams will have direct contact as a minimum 
by telephone or email before the handover of the young person, and document it. There should be at 
least two direct contacts between the paediatric and adult rheumatologist during the process of 
transition: 
i) one member of the paediatric team: announcing transfer of patient 
ii) one member of the adult team: feedback confirming that the patient has been seen for at 
least the first two visits in adult care. 
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